retatrutide phase 2 results 2024 2025 Results: 24.2% Weight Loss (NEJM) retatrutide phase 2 results 2024

Beyond weight loss: Integrating GLP-1 RA therapies into psychological and behavioral care for obesity and binge eating disorder

Temperature extremes (moving from cold air into heated buildings) Hot beverages, spicy foods, and alcohol Stress and intense emotions Exercise and physical exertion These triggers cause temporary redness that typically resolves within 30 minutes to an hour once the stimulus stops

By binding to GLP-1 receptors throughout the body, semaglutide enhances insulin secretion when blood glucose levels are elevated, suppresses glucagon release, and slows gastric emptying

This results in substantially improved weight loss (WL) compared to conventional WL drugs